R

Regulus Therapeutics
D

RGLS

1.33000
USD
0.06
(4.31%)
مغلق
حجم التداول
4,396
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
87,115,178
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    A
    AXSM
    8.550
    (6.62%)
    137.720 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    D
    DVAX
    0.000
    (0.00%)
    13.335 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    F
    FOLD
    0.09500
    (1.05%)
    9.16000 USD
    I
    IONS
    -0.365
    (-1.12%)
    32.310 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    المزيد
الأخبار
المقالات

العنوان: Regulus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.